Illumina acquires BlueBee to speed NGS

By The Science Advisory Board staff writers

June 18, 2020 -- Illumina has acquired BlueBee, a Dutch genomics analysis software firm that originated as a spinoff from Delft University of Technology, in an effort to boost its next-generation sequencing (NGS) capability.

The purchase will also help Illumina lower the cost of storing, sharing, and managing genomic data from the company's installed base of more than 15,000 sequencing systems.

BlueBee's offerings include BlueFlow, an analysis management tool; BlueBase, a multimodal data management tool; and BlueBench, data science and artificial intelligence tools. These capabilities will complement Illumina's BaseSpace Sequencing Hub, software for sequencing run management and data sharing, it said.

Terms of the acquisition were not released.

If you like this content, please share it with a colleague!

Related Reading

Thermo Fisher Scientific optimizes NGS platform for COVID-19
To expedite genomic analysis of COVID-19 resurgent strains, Thermo Fisher Scientific has optimized its Ion AmpliSeq SARS-CoV-2 research panel for use...

Illumina makes SARS-CoV-2 NGS toolkit free of charge
Illumina is making its SARS-CoV-2 data toolkit, a suite of data analysis tools and workflow functionality, free for researchers researching the virus...

Arbor offers NGS coronavirus panel to researchers for free
Arbor Biosciences announced on February 12 that it will release its myBaits Expert hybridization-based panel for detecting infection with the 2019 novel...

NGS of China coronavirus shows bat origins, intermediate host
Next-generation sequencing (NGS) of 10 genomes of novel coronavirus (2019-nCoV) from nine patients in China demonstrated that the virus is closely related...

Enrichment NGS emerges as surveillance tool for coronavirus
As the coronavirus continues to grow as a global health concern, researchers urgently seek efficient methods to predict and mitigate emerging coronavirus...